Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: Implications for vaccine efficacy evaluation-Reference-Cited by-同舟云学术

Virological confirmation of suspected dengue in a Phase 2 Latin American vaccine trial: Implications for vaccine efficacy evaluation

Published:2014 Issue: Volume:3 Page:127-133
ISSN:1879-4378
Container-title:Trials in Vaccinology
language:en
Short-container-title:Trials in Vaccinology

Author:

Boaz Mark,Janosczyk Helene,Garg Seema,Yost Stacy,Hildreth Stephen W.,Dayan Gustavo,Starr-Spires Linda

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Microbiology

Reference24 articles.

1. D.S. Burke, T.P. Monath, 4th ed., in: D.M. Knipe, P.M. Howley (Eds.), Fields Virology, Lippincott Williams & Wilkins: Philadelphia, PA, 2001; vol. 1, pp. 1043–1125.

2. World Health Organization (WHO). Dengue: guidelines for diagnosis, treatment, prevention and control. Available online: http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf (accessed on 1 August 2012).

3. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality;San Martn;Am. J. Trop. Med. Hyg.,2010

4. Pan American Health Organization (PAHO). Dengue. Available online: http://new.paho.org/hq/index.php?option=com_content&task=view&id=264&Itemid=363&lang=es (accessed on 1 August 2012).

5. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates;Guirakhoo;J. Virol.,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective surveillance of Zika virus at the end of the Americas’ outbreak: An unexpected outcome;Frontiers in Tropical Diseases;2022-10-24

2. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas;The American Journal of Tropical Medicine and Hygiene;2019-09-04

3. Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials;Clinical Infectious Diseases;2017-12-30

4. Immunogenicity and Safety of a Booster Injection of DTap-IPV//Hib (Pentaxim) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers 15–18 Months of Age in Mexico;Pediatric Infectious Disease Journal;2017-06

5. Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease;Drugs;2016-08-09